Civic Intelligence

Als Cure Project Inc.

990 • Fiscal year 2021 • EIN 84-3289802

Jan 01, 2021 to Dec 31, 2021 • Filed on May 16, 2022

2808 Longspur WayPleasanton, CA 94566-5206

(925) 321-5487

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

29th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2021

Liabilities / Revenue

29th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2021

Net Margin

83rd percentile

43%

Higher net margin than 83% of similar nonprofits.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2021

Top Officer Pay

52nd percentile

$0

Higher top officer pay than 52% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2021

Asset Growth

95th percentile

187%

Faster asset growth than 95% of similar nonprofits.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2020 to 2021

Revenue Growth

15th percentile

-23%

Faster revenue growth than 15% of similar nonprofits.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2020 to 2021

Assets

Up

$265,376

Up $172,766 (+187%) from 2020

Net Assets

Up

$265,376

Up $172,766 (+187%) from 2020

Liabilities

Flat

$0

Flat from 2020

Revenue

Down

$404,785

Down $118,988 (-23%) from 2020

Expenses

Down

$232,019

Down $199,144 (-46%) from 2020

Net Income

Up

$172,766

Up $80,156 (+87%) from 2020

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0Assets 2020: $92,610Liabilities 2020: $0Net Assets 2020: $92,6102020Assets 2021: $265,376Liabilities 2021: $0Net Assets 2021: $265,3762021Assets 2022: $178,157Liabilities 2022: $0Net Assets 2022: $178,1572022Assets 2023: $98,318Liabilities 2023: $0Net Assets 2023: $98,3182023Assets 2024: $739,634Liabilities 2024: $0Net Assets 2024: $739,6342024

Highlighted filing

2021

Assets$265,376
Liabilities$0
Net Assets$265,376

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2020: $523,773Expenses 2020: $431,163Net Income 2020: $92,6102020Revenue 2021: $404,785Expenses 2021: $232,019Net Income 2021: $172,7662021Revenue 2022: $158,344Expenses 2022: $245,563Net Income 2022: -$87,2192022Revenue 2023: $164,489Expenses 2023: $244,328Net Income 2023: -$79,8392023Revenue 2024: $860,387Expenses 2024: $219,071Net Income 2024: $641,3162024

Highlighted filing

2021

Revenue$404,785
Expenses$232,019
Net Income$172,766
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
May 16, 2022
Return Version
2021v4.2
Gross Receipts
$745,677
Mission and Program Overview

Mission

The specific purpose of the Organization shall include without limitation to lead scientific research focused on the identification of Amyotrophic Lateral Sclerosis (ALS) bio-markers and disease mechanism with the ultimate goal of finding a cure for ALS.

The specfic purpose of the Organization shall include without limitation, to lead scientific research focused on the identification of Amyotrophic Lateral Scierosis ALS bio-markers and disease mechanism

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$88,933$233,276▲ $144,343
Prepaid Expenses and Deferred Charges$3,677$32,100▲ $28,423
Total Assets$92,610$265,376▲ $172,766
Liabilities
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$92,610$265,376▲ $172,766
Total Net Assets Fund Balance$92,610$265,376▲ $172,766
Total Liabilities and Net Assets / Fund Balance$92,610$265,376▲ $172,766
Compensation and Service Providers

Board Members and Trustees

NameTitle
Mike PiscottyPresident
Stephen PiscottyVIce President
Phil GreenCorporate Sponsorship Director
James GilbrethFund Raising Director
Andrew WoodwardIT Communications Director
Mike CrawfordOutreach Director
Jim PooleStrategic Partnership Director
Toni EslickSecretary
Barron WesenbergTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$404,785
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$110,337
Change in Net Assets
$172,766
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$225,000
Other Expenses$7,019
Total Fundraising Expense$5,432
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$225,000--$225,000
Information Technology--$3,095$3,095
Office Expenses--$2,337$2,337
Insurance-$1,487-$1,487
Fees for Services Legal-$100-$100
Total Functional Expenses$225,000$1,587$5,432$232,019
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Livermore Lab FoundationOakland, CA-Research for biomarkers$180,000
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$340,892
Fundraising Gross Income$340,892
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Country Fest$154,300$136,790$17,068$119,722
Crawford Golf$200,233$60,303$22,430$37,873
Total Events$635,339$340,892$340,892-
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 8B

Meeting minutes are taken at each meeting and distributed to all members for review

Form 990, Part VI, Section B, Line 11B

A full and unredacted copy of this form 990 including schedules will be provided to all board memebers via email for review before filing

Form 990, Part VI, Section B, Line 12C

Pursuant to the organizations Conflicts of Interest Policy, all Board Memebers and Officers are required at minimum to confirm or report in writing the existence/absence of any conflicts of interest at the annual meeting. Also, Board Memebers and Officers are required to inorm the board, in writing, that a conflict of interest has arisen at any time during the year as well.

Form 990, Part VI, Section C, Line 19

The organizations website alscure.net provides the email address of the President for inguiries from the general public and the organization has a profile on guidestar.org that provides the tax documents of the organization.

Form 990, Part VI, Section A, Line 2

Mike Piscotty Family Relationship Stephen Piscotty Barron Wesenberg Business Relationship James Gilbreth

Filing and Contact Details

Filer

Filer Name
Als Cure Project Inc
EIN
84-3289802
In Care Of
% Barron Wesenberg
Phone
9253215487
Address
2808 LONGSPUR WAY, Pleasanton, CA 94566-5206

Signing Officer

Name
Barron Wesenberg
Title
Treasurer
Signed
2022-05-16
Discuss with paid preparer
No

Organization Details

Principal Officer
Mike Piscotty
Formed
2019
Legal Domicile
CA
Voting Board Members
9
Independent Board Members
9
Employees
0
Volunteers
20
Supplemental Narrative

Additional Explanations

Form 990, Part I, Line 1

The Specfic purpose of the Organization shall include without limitation, to lead scientific research on the indentification of Amyotrophic Lateral Scierssis ALS bio-markers and diease mechanism with the ultimate goal of finding a cure for ALS.

Form 990, Part III, Line 2

ALS Cure Project has fuunded Physics based modeling project using the worlds fastest supercomputer at Lawerance Livermore Labs to help identify and understand the ALS disease mechanism. The initial focus will be on the formation of the aberrant TAR DNA-binfding protein TDP-43 inclusions or cluster that transition into pathological, amyloid-like fibrils.

Raw XML Appendix391 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0The specfic purpose of the Organization shall include without limitation, to lead scientific research focused on the identification of Amyotrophic Lateral Scierosis ALS bio-markers and disease mechanism
IRS990/AdvertisingGrp/TotalAmt00
IRS990/AllOtherContributionsAmt0110337
IRS990/AllOtherExpensesGrp/TotalAmt00
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BenefitsToMembersGrp/TotalAmt00
IRS990/BooksInCareOfDetail/PersonNm0Barron Wesenberg
IRS990/BooksInCareOfDetail/PhoneNum09253215487
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt02808 Longspur
IRS990/BooksInCareOfDetail/USAddress/CityNm0Pleasanton
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094566
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt088933
IRS990/CashNonInterestBearingGrp/EOYAmt0233276
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt00
IRS990/CompDisqualPersonsGrp/TotalAmt00
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/TotalAmt00
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/ContriRptFundraisingEventAmt0294448
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0404785
IRS990/CYGrantsAndSimilarPaidAmt0225000
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt07019
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0172766
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0232019
IRS990/CYTotalFundraisingExpenseAmt05432
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0404785
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/TotalAmt00
IRS990/Desc0ALS Cure Project continued to fund the Physics based modeling project using the worlds fastest supercomputer at Lawerance Livermore Lab to help idenity and understand the ALS disease mechanism. The initial focus will be on the formation of the aberrant TAR DNA- binding protien 43 TDP-43 inclusions or cluster that transition into pathological, amyyloid-like fibrils
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0140000
IRS990/FamilyOrBusinessRlnInd0true
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/TotalAmt00
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0100
IRS990/FeesForServicesLegalGrp/TotalAmt0100
IRS990/FeesForServicesLobbyingGrp/TotalAmt00
IRS990/FeesForServicesManagementGrp/TotalAmt00
IRS990/FeesForServicesOtherGrp/TotalAmt00
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt00
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignGrantsGrp/TotalAmt00
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt0010.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1001.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2006.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt3006.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt4003.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt5003.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt6003.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt7003.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt8003.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/PersonNm0Mike Piscotty
IRS990/Form990PartVIISectionAGrp/PersonNm1Stephen Piscotty
IRS990/Form990PartVIISectionAGrp/PersonNm2Toni Eslick
IRS990/Form990PartVIISectionAGrp/PersonNm3James Gilbreth
IRS990/Form990PartVIISectionAGrp/PersonNm4Barron Wesenberg
IRS990/Form990PartVIISectionAGrp/PersonNm5Andrew Woodward
IRS990/Form990PartVIISectionAGrp/PersonNm6Phil Green
IRS990/Form990PartVIISectionAGrp/PersonNm7Mike Crawford
IRS990/Form990PartVIISectionAGrp/PersonNm8Jim Poole
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/TitleTxt0President
IRS990/Form990PartVIISectionAGrp/TitleTxt1VIce President
IRS990/Form990PartVIISectionAGrp/TitleTxt2Secretary
IRS990/Form990PartVIISectionAGrp/TitleTxt3Fund Raising Director
IRS990/Form990PartVIISectionAGrp/TitleTxt4Treasurer
IRS990/Form990PartVIISectionAGrp/TitleTxt5IT Communications Director
IRS990/Form990PartVIISectionAGrp/TitleTxt6Corporate Sponsorship Director
IRS990/Form990PartVIISectionAGrp/TitleTxt7Outreach Director
IRS990/Form990PartVIISectionAGrp/TitleTxt8Strategic Partnership Director
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02019
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0true
IRS990/FundraisingAmt0294448
IRS990/FundraisingDirectExpensesAmt0340892
IRS990/FundraisingGrossIncomeAmt0340892
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt09
IRS990/GrantAmt0140000
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt00
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0225000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0225000
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0true
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0745677
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt09
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt03095
IRS990/InformationTechnologyGrp/TotalAmt03095
IRS990/InsuranceGrp/ManagementAndGeneralAmt01487
IRS990/InsuranceGrp/TotalAmt01487
IRS990/InterestGrp/TotalAmt00
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd0false
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0ALS Cure Project has funded Physics based modeling project using the worlds fastest supercomputer at Lawerance Livermore Labs to help identify and understand the disease mechanism. The initial focus will be on the formation of the aberrant TAR-DNA-binding protein 43 TDO-43 inclusions or that transistion into pathological, amyloid-like fibrils
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt092610
IRS990/NetAssetsOrFundBalancesEOYAmt0265376
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt092610
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0265376
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/TotalAmt00
IRS990/OfficeExpensesGrp/FundraisingAmt02337
IRS990/OfficeExpensesGrp/TotalAmt02337
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherEmployeeBenefitsGrp/TotalAmt00
IRS990/OtherSalariesAndWagesGrp/TotalAmt00
IRS990/OtherWebsiteInd0X
IRS990/OwnWebsiteInd0X
IRS990/PartialLiquidationInd0false
IRS990/PaymentsToAffiliatesGrp/TotalAmt00
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/TotalAmt00
IRS990/PensionPlanContributionsGrp/TotalAmt00
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt03677
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt032100
IRS990/PrincipalOfficerNm0Mike Piscotty
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgSrvcAccomActy2Grp/Desc0ALS Cure Project funded a pilot program to evaluate the applicability of LLNLs Brain-on-chip platform to support an in vitro ALS model recapitulating key disease phenotype. This capability can then be used to probe neuronal function as a readout of efficacy to therapeutic compounds, including those being developed at Prosetta Biosciences.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt040000
IRS990/ProgSrvcAccomActy2Grp/GrantAmt040000
IRS990/ProgSrvcAccomActy3Grp/Desc0The ALS Cure Project hosted the ALS Innovation Symposim held virtual on November 17th and December 1st and included 115 international ALS researchers from 10 nations where participants worked collaboratively in workshop styled breakouts to create the symposiums product, the 2021 Roadmap to Cure ALS. The event was also co-sponsored by Mitsubishi Tanabe Pharma America MTPA
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt045000
IRS990/ProgSrvcAccomActy3Grp/GrantAmt045000
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt0523773
IRS990/PYExcessBenefitTransInd0false
IRS990/PYGrantsAndSimilarPaidAmt0420000
IRS990/PymtTravelEntrtnmntPubOfclGrp/TotalAmt00
IRS990/PYOtherExpensesAmt011163
IRS990/PYRevenuesLessExpensesAmt092610
IRS990/PYTotalExpensesAmt0431163
IRS990/PYTotalRevenueAmt0523773
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt0172766
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RoyaltiesGrp/TotalAmt00
IRS990ScheduleA/First5Years509Ind0X
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt0404785
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0523773
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0928558
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt00
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt00
IRS990ScheduleA/OtherIncome509Grp/TotalAmt00
IRS990ScheduleA/Post1975UBTIGrp/TotalAmt00
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.00000
IRS990ScheduleA/PublicSupportTotal509Amt0928558
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0404785
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0523773
IRS990ScheduleA/Total509Grp/TotalAmt0928558
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0404785
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0523773
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0928558
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleG/AgrmtProfFundraisingActyInd0false
IRS990ScheduleG/FundraisingEventInformationGrp/CharitableContributionsTotAmt0294447
IRS990ScheduleG/FundraisingEventInformationGrp/CharitableContriEvent1Amt0139930
IRS990ScheduleG/FundraisingEventInformationGrp/CharitableContriEvent2Amt017510
IRS990ScheduleG/FundraisingEventInformationGrp/CharitableContriOtherEventsAmt0137007
IRS990ScheduleG/FundraisingEventInformationGrp/DirectExpenseSummaryEventsAmt0340892
IRS990ScheduleG/FundraisingEventInformationGrp/EntertainmentEvent2Amt052823
IRS990ScheduleG/FundraisingEventInformationGrp/EntertainmentTotalEventsAmt052823
IRS990ScheduleG/FundraisingEventInformationGrp/Event1Nm0Crawford Golf
IRS990ScheduleG/FundraisingEventInformationGrp/Event2Nm0Country Fest
IRS990ScheduleG/FundraisingEventInformationGrp/FoodAndBeverageEvent2Amt046749
IRS990ScheduleG/FundraisingEventInformationGrp/FoodAndBeverageOtherEventsAmt026576
IRS990ScheduleG/FundraisingEventInformationGrp/FoodAndBeverageTotalEventsAmt073325
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsEvent1Amt0200233
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsEvent2Amt0154300
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsOtherEventsAmt0280806
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsTotalAmt0635339
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueEvent1Amt060303
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueEvent2Amt0136790
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueOtherEventsAmt0143799
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueTotalEventsAmt0340892
IRS990ScheduleG/FundraisingEventInformationGrp/OthDirectExpnssOtherEventsAmt088664
IRS990ScheduleG/FundraisingEventInformationGrp/OthDirectExpnssTotalEventsAmt0128162
IRS990ScheduleG/FundraisingEventInformationGrp/OtherDirectExpensesEvent1Amt022430
IRS990ScheduleG/FundraisingEventInformationGrp/OtherDirectExpensesEvent2Amt017068
IRS990ScheduleG/FundraisingEventInformationGrp/OtherEventsTotalCnt08
IRS990ScheduleG/FundraisingEventInformationGrp/RentFacilityCostsEvent1Amt037873
IRS990ScheduleG/FundraisingEventInformationGrp/RentFacilityCostsEvent2Amt020150
IRS990ScheduleG/FundraisingEventInformationGrp/RentFcltyCostsOtherEventsAmt028559
IRS990ScheduleG/FundraisingEventInformationGrp/RentFcltyCostsTotalEventsAmt086582
IRS990ScheduleG/SpecialFundraisingEventsInd0X
IRS990ScheduleI/GrantRecordsMaintainedInd0true
IRS990ScheduleI/RecipientTable/CashGrantAmt0180000
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0Research for biomarkers
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0Livermore Lab Foundation
IRS990ScheduleI/RecipientTable/RecipientEIN0812567763
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt01111 Franklin Street
IRS990ScheduleI/RecipientTable/USAddress/CityNm0Oakland
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0CA
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd094607
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0All progress/results are monitored by the research council. Funds are staggered and timed to release as activities occur
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I Line 2
IRS990ScheduleI/TotalOtherOrgCnt01
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0The Specfic purpose of the Organization shall include without limitation, to lead scientific research on the indentification of Amyotrophic Lateral Scierssis ALS bio-markers and diease mechanism with the ultimate goal of finding a cure for ALS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ALS Cure Project has fuunded Physics based modeling project using the worlds fastest supercomputer at Lawerance Livermore Labs to help identify and understand the ALS disease mechanism. The initial focus will be on the formation of the aberrant TAR DNA-binfding protein TDP-43 inclusions or cluster that transition into pathological, amyloid-like fibrils.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Meeting minutes are taken at each meeting and distributed to all members for review
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3A full and unredacted copy of this form 990 including schedules will be provided to all board memebers via email for review before filing
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4Pursuant to the organizations Conflicts of Interest Policy, all Board Memebers and Officers are required at minimum to confirm or report in writing the existence/absence of any conflicts of interest at the annual meeting. Also, Board Memebers and Officers are required to inorm the board, in writing, that a conflict of interest has arisen at any time during the year as well.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5The organizations website alscure.net provides the email address of the President for inguiries from the general public and the organization has a profile on guidestar.org that provides the tax documents of the organization.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6Mike Piscotty Family Relationship Stephen Piscotty Barron Wesenberg Business Relationship James Gilbreth
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990, Part I, Line 1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990, Part III, Line 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990, Part VI, Section A, Line 8b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Form 990, Part VI, Section B, Line 11b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Form 990, Part VI, Section B, Line 12c
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Form 990, Part VI, Section C, Line 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Form 990, Part VI, Section A, Line 2
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt092610
IRS990/TotalAssetsEOYAmt0265376
IRS990/TotalAssetsGrp/BOYAmt092610
IRS990/TotalAssetsGrp/EOYAmt0265376
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt0404785
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt05432
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt01587
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0225000
IRS990/TotalFunctionalExpensesGrp/TotalAmt0232019
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt092610
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0265376
IRS990/TotalProgramServiceExpensesAmt0225000
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0404785
IRS990/TotalVolunteersCnt020
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt092610
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0265376
IRS990/TravelGrp/TotalAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt02808 Longspur Way
IRS990/USAddress/CityNm0Pleasanton
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd094566
IRS990/VotingMembersGoverningBodyCnt09
IRS990/VotingMembersIndependentCnt09
IRS990/WebsiteAddressTxt0alscure.net
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0false
ReturnHeader/BusinessOfficerGrp/PersonNm0Barron Wesenberg
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Treasurer
ReturnHeader/BusinessOfficerGrp/SignatureDt02022-05-16
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ALS CURE PROJECT INC
ReturnHeader/Filer/BusinessNameControlTxt0ALSC
ReturnHeader/Filer/EIN0843289802
ReturnHeader/Filer/InCareOfNm0% Barron Wesenberg
ReturnHeader/Filer/PhoneNum09253215487
ReturnHeader/Filer/USAddress/AddressLine1Txt02808 LONGSPUR WAY
ReturnHeader/Filer/USAddress/CityNm0Pleasanton
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd0945665206
ReturnHeader/ReturnTs02022-05-24T03:42:56-00:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0Barron
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0Wesenberg
ReturnHeader/TaxPeriodBeginDt02021-01-01
ReturnHeader/TaxPeriodEndDt02021-12-31
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings